Literature DB >> 17562402

The effects of technique changes on aseptic loosening of the femoral component in hip resurfacing. Results of 600 Conserve Plus with a 3 to 9 year follow-up.

Harlan C Amstutz1, Michel J Le Duff, Patricia A Campbell, Frederick J Dorey.   

Abstract

The purpose of the present study was to determine the effectiveness of modifications in the surgical technique on loosening of the femoral component in the first 600 consecutive Conserve Plus metal-on-metal hybrid resurfacings (Wright Medical Technologies, Arlington, Tenn). These modifications were gradually introduced over time, but all the changes were implemented after the first 300 hips. The average age of the patients was 48.9 years, and 74% were male. The average follow-up was 70.5 months for the first 300 hips and 42.4 months for the second 300, and there was a significant improvement (P = .016) of the second 300 hips over the first 300 in a time-dependent analysis using as an end point the time to appearance of a radiolucency, suggesting potential femoral component loosening. None of the components with cemented stems showed femoral radiolucencies or were revised for aseptic loosening. Adding fixation holes in the dome and chamfered areas and cleansing and drying using a suction tip in the dome hole were significantly related to the improvement of the results. Positioning the femoral component in a more valgus position did not show any effect as an independent variable.

Entities:  

Mesh:

Year:  2007        PMID: 17562402     DOI: 10.1016/j.arth.2006.08.001

Source DB:  PubMed          Journal:  J Arthroplasty        ISSN: 0883-5403            Impact factor:   4.757


  20 in total

1.  2008 Otto Aufranc Award: component design and technique affect cement penetration in hip resurfacing.

Authors:  Paul E Beaulé; Wadih Y Matar; Philippe Poitras; Kevin Smit; Olivier May
Journal:  Clin Orthop Relat Res       Date:  2008-10-16       Impact factor: 4.176

2.  Cementing the metaphyseal stem in metal-on-metal resurfacing: when and why.

Authors:  Harlan C Amstutz; Michel J Le Duff
Journal:  Clin Orthop Relat Res       Date:  2008-10-30       Impact factor: 4.176

3.  Hip resurfacing arthroplasty: risk factors for failure over 25 years.

Authors:  Eric J Yue; Miguel E Cabanela; Gavan P Duffy; Michael G Heckman; Mary I O'Connor
Journal:  Clin Orthop Relat Res       Date:  2008-09-24       Impact factor: 4.176

4.  Hip resurfacing results for osteonecrosis are as good as for other etiologies at 2 to 12 years.

Authors:  Harlan C Amstutz; Michel J Le Duff
Journal:  Clin Orthop Relat Res       Date:  2009-09-12       Impact factor: 4.176

Review 5.  [Results of 5 to 10-year follow-up after hip resurfacing. A systematic analysis of the literature on long-term results].

Authors:  M C M Klotz; S J Breusch; M Hassenpflug; R G Bitsch
Journal:  Orthopade       Date:  2012-06       Impact factor: 1.087

6.  Acetabular component thickness does not affect mid-term clinical results in hip resurfacing.

Authors:  Mariam Al-Hamad; Michel J Le Duff; Karren M Takamura; Harlan C Amstutz
Journal:  Clin Orthop Relat Res       Date:  2014-01-22       Impact factor: 4.176

7.  Are There Long-term Benefits to Cementing the Metaphyseal Stem in Hip Resurfacing?

Authors:  Harlan C Amstutz; Michel J Le Duff; Sandeep K Bhaurla
Journal:  Clin Orthop Relat Res       Date:  2015-06-23       Impact factor: 4.176

8.  Hip resurfacing data from national joint registries: what do they tell us? What do they not tell us?

Authors:  Kristoff Corten; Steven J MacDonald
Journal:  Clin Orthop Relat Res       Date:  2010-02       Impact factor: 4.176

Review 9.  [Metal-on-metal hybrid hip resurfacing. Development and current state].

Authors:  M Hoberg; M J Le Duff; H C Amstutz
Journal:  Orthopade       Date:  2008-07       Impact factor: 1.087

Review 10.  [Biomechanical aspects of the implant fixation and kinematics of hip resurfacing systems].

Authors:  R Bader; D Klüss; L Gerdesmeyer; E Steinhauser
Journal:  Orthopade       Date:  2008-07       Impact factor: 1.087

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.